SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06208033 · UNKNOWN
Trial details
- NCT number
- NCT06208033
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-10
- Primary completion
- 2024-10-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.